Printer Friendly

Tri-Vision Technologies Signs First Commercialization Agreement; UK's Largest Healthcare Retailer to Distribute Pheromone's Fertility Monitor.

Business Editors/Health & Medical Writers

TORONTO--(BUSINESS WIRE)--June 18, 2002

Tri-Vision International Ltd./Ltee (TSX:TVL) and Pheromone Sciences Corp. (TSX Venture Exchange:PHS), a Toronto-based biotech R & D company with proprietary technology in the field of non-invasive fertility and ovulation detection are pleased to announce the signing of a Letter of Intent (LOI) for the distribution of Pheromone's PSC Fertility Monitor(TM) in the United Kingdom. The LOI is expected to be followed by a definitive Distribution Agreement. The distribution agreement is to provide for the sale of the PSC Fertility Monitor exclusively in Boots Company PLC stores across the United Kingdom over a three-year period.

Boots is the UK's largest retailer of health products in the United Kingdom with over 1,400 retail outlets and a strong Internet-based pharmacy network. Under the proposed distribution agreement Boots would be committed to selling a significant number of units of the product during each year to maintain exclusivity. The product is expected to be available in Boots outlets before year-end.

The PSC Fertility Monitor is a fertility cycle monitoring device for the consumer and professional medical market. The PSC Fertility Monitor looks to set a new benchmark in providing a reliable "predictive" approach to natural, cycle-based family planning. The PSC Fertility Monitor is a non-invasive method of predicting the fertility window and ovulation date through the measurements of perspiration ion changes on the surface of the skin through a unique combination of bio-sensing and computer technologies. These changes in female perspiration allow for the prediction of ovulation up to 4 days before the ovulation day.

Pheromone advises that in their recent US trial, the PSC Fertility Monitor detected more days of the conception window (the days when sexual intercourse can lead to a pregnancy) than the LH test strip product or the basal body temperature method. This determination, coupled with the published literature on the chances of conception during this window strongly suggests that women who use the PSC Fertility Monitor as a means of identifying their fertile window to time intercourse, can expect a substantially higher probability of conception or a substantially shorter time to pregnancy than if they relied solely on home-based LH test kits as a means to time intercourse.

This business agreement is the first for Tri-Vision's newly-established subsidiary, Tri-Vision Technologies International Inc., which was created for the development and marketing of innovative technologies.

"While this is our first endeavor in delivering new technologies for other companies, our core business has been operating internationally for years and we continue to show success with our V-chip licensing to internationally-based television manufacturers. This relationship with Pheromone and Boots is a clear demonstration of Tri-Vision Technologies' ability to market internationally" stated Tri-Vision Technologies President Toshinori Ikebe.

"The signing of this LOI represents a significant step in the execution of our commercialization strategy" stated Christopher Neuman President and CEO of Pheromone. "Much effort has been put into the development of our Fertility Monitor technology and this solid expression of interest from one of the world's leading health care retailing organizations is a validation of our efforts to bring this technology to couples around the world."

Tri-Vision International Ltd./Ltee is a public company founded in 1986. The Company trades on Canada's Toronto Stock Exchange under the symbol TVL. The public company has two wholly owned subsidiaries: Tri-Vision Electronics Inc. and Tri-Vision Technologies International Inc.

For investor or media information, contact John Carswell, Century Communications Corporation toll free at 1-888-298-8551. For further information, visit the Company's website at www.tri-vision.ca.

The Toronto Stock Exchange has not reviewed and does not approve or disapprove of the adequacy or accuracy of this release.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 18, 2002
Words:611
Previous Article:Nasdaq Liffe Markets Selects CenterBeam for End-User Computing Services.
Next Article:Avistar Showcases Diversity of Video Communications at SIA Tech Conference; Syntegra's ITS Video Turret, Avistar vBrief Video Email Supported by...
Topics:


Related Articles
Pheromone cuts down a male's flirting time.
Mice have a sharp nose for pheromones.
Track staff development. (New products: tools for schools).
Internet independent study. (New products: tools for schools).
Furniture stores move to SoHo. (Retail New York).
Visionary research: scientists delve into the evolution of color vision in primates.
Grow-slow potion: pheromone keeps bee youngsters youthful.
The politics of the gay gene.
Ant trails.
Science news resources.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters